Discover 1,293 paid clinical trials in Scottsdale, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,293
Active & Responsive
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
for
Kidney Disease
Location: Surprise AZ, Albuquerque NM, Orange CA, El Paso TX,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06963827
Phase 3, Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Scottsdale AZ, Phoenix AZ, Tempe AZ, Gilbert AZ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase 3, Recruiting
IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Scottsdale AZ, Phoenix AZ, Orange CA, Fullerton CA,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Scottsdale AZ, Sun City AZ, Albuquerque NM, Irvine CA,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07304089
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
for
Ocular Myasthenia Gravis
Location: Scottsdale AZ, O'Fallon IL, Greenfield WI, Columbus OH,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 18+
Code: NCT07463521
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
for
Bone Metastases
Location: Scottsdale AZ, Los Angeles CA, Salt Lake UT,
Sponsor: American College of Radiology - Image Metrix
Sex: All
Age: 18+
Code: NCT00882609
Phase 3, Recruiting
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes